Hutch News

Stories tagged 'Ovarian Cancer'

Good News at Fred Hutch

Celebrating faculty and staff achievements

May 12, 2017 | By Kristen Woodward / Fred Hutch News Service

Eight Fred Hutch/University of Washington researchers receive pilot awards that support a range of innovative concepts with the potential to improve cancer patients' lives.

View story >


Dissolving implant could bring immunotherapy to solid tumors

A biopolymer sponge delivers cancer-shrinking T-cell therapy in preclinical study

April 24, 2017 | By Sabrina Richards / Fred Hutch News Service

A dissolving scaffold developed by Dr. Matthias Stephan delivers engineered anti-tumor immune cells to crowded masses of tumor cells and recruits the native immune system to mount a second-wave attack on the cancer.

View story >


Immunotherapy for ovarian cancer shows promise in mouse model, but hurdles remain

‘Tumor microenvironment’ poses unique challenges for T-cell therapy in solid tumors

April 4, 2017 | By Rachel Tompa / Fred Hutch News Service

A major roadblock to adopting T-cell therapy to solid tumors is what’s known as the tumor microenvironment, the local milieu of non-cancerous cells and molecules in and around the tumor. Fred Hutch researcher Dr. Kristin Anderson and her colleagues in Dr. Phil Greenberg's lab are working to overcome those barriers.

View story >


Finding ways to deliver on the promise of precision oncology

‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients

March 31, 2017 | By Rachel Tompa / Fred Hutch News Service

Dr. Christopher Kemp is confident that the answer to personalized cancer treatment is written in the molecules inside each patient’s tumor, we just need to figure out how to separate the wheat from the chaff.

View story >


A Q&A with Fred Hutch postdoctoral research fellow Dr. Rachel Perret

As part of a world-class immunotherapy research team, Perret is working her ‘dream job’ — trying to bring T-cell therapy to all who need it

Jan. 9, 2017 | By Rachel Tompa / Fred Hutch News Service

A postdoctoral research fellow training under the mentorship of immunotherapy expert Dr. Phil Greenberg, Dr. Rachel Perret is working toward an “off-the-shelf” version of T-cell therapy.

View story >


So you're BRCA, now what?

A Fred Hutch researcher and breast cancer survivor talks about her inherited mutation and how it helped guide her decisions

Nov. 8, 2016 | By Diane Mapes / Fred Hutch News Service

As research sheds ever more light on hereditary cancers and the genes that cause them, a portion of the population is being faced with some very difficult choices. Do you test or not test? Share information about deadly mutations with relatives or keep it to yourself? Get preventive surgery or blindly hope cancer doesn’t strike? A Fred Hutch researcher, BRCA carrier and cancer survivor, takes us through her decision-making process.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.